Document Detail


Repeated high-dose inhalation allergen challenge in asthma.
MedLine Citation:
PMID:  21679350     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Introduction:  Inhalation allergen challenge in humans is used to investigate lung pathophysiology and responses to novel therapies. However, the single high-dose allergen challenges that are commonly performed do not mimic repeated symptomatic environmental allergen exposure. Objectives:  To develop and evaluate the safety of a repeated high-dose symptomatic inhalation allergen challenge model. Methods:  Sixteen subjects with atopic asthma were recruited. Each underwent three inhalation allergen challenges using house dust mite (Dermatophagoides pteronyssinus) antigen at 48-h intervals with a target of symptom induction and an early asthmatic reaction fall in forced expiratory volume in 1 s (FEV(1) ) of 15% from baseline. Results:  All of the subjects completed the three-challenge protocol and the target immediate airway bronchoconstrictor response was achieved in all the subjects at all challenges. There were no adverse events recorded. The early asthmatic reaction was similar for the three challenges whether measured as mean maximal fall in FEV(1) or mean area under the curve. The late asthmatic reaction was also similar over the three challenges with no evidence of priming or desensitisation. Symptom scores and reliever medication use significantly increased over the time of the challenges. Baseline lung function and reversibility was unchanged 4 days after the last challenge. Conclusion:  We demonstrate that repeated high-dose inhaled house dust mite allergen challenge in human volunteers with mild asthma is safe, repeatable and acceptable. This allows the use of this model in further studies focused on understanding the pathophysiology of allergen induced asthma and the impact of therapeutic interventions. Please cite this paper as: Grainge C and Howarth PH. Repeated high-dose inhalation allergen challenge in asthma. Clin Respir J 2011; 5: 150-155.
Authors:
Christopher Grainge; Peter Hugo Howarth
Publication Detail:
Type:  Journal Article     Date:  2010-06-07
Journal Detail:
Title:  The clinical respiratory journal     Volume:  5     ISSN:  1752-699X     ISO Abbreviation:  Clin Respir J     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-06-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101315570     Medline TA:  Clin Respir J     Country:  England    
Other Details:
Languages:  eng     Pagination:  150-5     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Affiliation:
University of Southampton School of Medicine, Infection, Inflammation and Immunology Division, Southampton General Hospital, Southampton, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Short-term prognosis of occupational asthma in a Finnish population.
Next Document:  Fatigue and plasma cytokine concentrations at rest and during exercise in patients with sarcoidosis.